bf/NASDAQ:CYTK_icon.png

COM:CYTOKINETICS

Cytokinetics, Incorporated

  • Stock

Last Close

55.50

07/11 21:00

Market Cap

6.30B

Beta: -

Volume Today

1.80M

Avg: -

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a nove...Show More

peer of

investor of